What is Immuneering Corporation Class A Common Stock's Market Cap?

Immuneering Corporation Class A Common Stock's Market Cap is $295.7M, based on as-reported figures from SEC (XBRL) filings.

What is Immuneering Corporation Class A Common Stock's Enterprise Value?

Immuneering Corporation Class A Common Stock's Enterprise Value is $254.3M, based on as-reported figures from SEC (XBRL) filings.

What is Immuneering Corporation Class A Common Stock's EV / EBITDA?

Immuneering Corporation Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Immuneering Corporation Class A Common Stock's Net Income (TTM)?

Immuneering Corporation Class A Common Stock's Net Income (TTM) is -$57.3M, based on as-reported figures from SEC (XBRL) filings.

What is Immuneering Corporation Class A Common Stock's Diluted EPS (TTM)?

Immuneering Corporation Class A Common Stock's Diluted EPS (TTM) is -0.89, based on as-reported figures from SEC (XBRL) filings.

Immuneering Corporation Class A Common Stock (IMRX) Financial Statements

Immuneering Corporation Class A Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG009QXJQV7

XNAS · usd

4.57▼ 0.04 (-0.87%)

As of 2026-09-10

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close4.61

Day's Range4.47 – 4.69

52-Week Range3.86 – 10.08

Volume623.9K

Avg Volume661.6K

Share Statistics

Shares Outstanding

Employees53

ExchangeXNAS

Listed2021-07-30

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Immuneering Corporation Class A Common Stock (IMRX)

What is Immuneering Corporation Class A Common Stock's Market Cap?: Immuneering Corporation Class A Common Stock's Market Cap is $295.7M, based on as-reported figures from SEC (XBRL) filings.
What is Immuneering Corporation Class A Common Stock's Enterprise Value?: Immuneering Corporation Class A Common Stock's Enterprise Value is $254.3M, based on as-reported figures from SEC (XBRL) filings.
What is Immuneering Corporation Class A Common Stock's EV / EBITDA?: Immuneering Corporation Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Immuneering Corporation Class A Common Stock's Net Income (TTM)?: Immuneering Corporation Class A Common Stock's Net Income (TTM) is -$57.3M, based on as-reported figures from SEC (XBRL) filings.
What is Immuneering Corporation Class A Common Stock's EBITDA?: Immuneering Corporation Class A Common Stock's EBITDA is -$63.1M, based on as-reported figures from SEC (XBRL) filings.
What is Immuneering Corporation Class A Common Stock's Diluted EPS (TTM)?: Immuneering Corporation Class A Common Stock's Diluted EPS (TTM) is -0.89, based on as-reported figures from SEC (XBRL) filings.
What is Immuneering Corporation Class A Common Stock's Net Debt?: Immuneering Corporation Class A Common Stock's Net Debt is -$41.3M, based on as-reported figures from SEC (XBRL) filings.